Fingerprint
Dive into the research topics of 'The SECURE study: long-term safety of Ranibizumab 0.5 mg in neovascular age-related macular degeneration'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The SECURE study: long-term safety of Ranibizumab 0.5 mg in neovascular age-related macular degeneration
Rufino Silva, Ruth Axer-Siegel, Bora Eldem, Robyn Guymer, Bernd Kirchhof, Andras Papp, Andras Seres, Margarita Gekkieva, Annette Nieweg, Stefan Pilz,
Research output: Contribution to journal › Article › peer-review